Home › Funds › Neumann Capital Management, LLC › GILD

Neumann Capital Management, LLC position in GILD

GILEAD SCIENCES INC · Health Care

Neumann Capital Management, LLC reported holding 37,368 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$5.6M, representing 1.42% of its reported portfolio and ranking #18 among its reported holdings. Neumann Capital Management, LLC has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)37.37K sh
Reported value held$5.57M
Portfolio Weight1.42%
First reportedQ3 2023
Last changeAdd
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How Neumann Capital Management, LLC's GILD position evolved

Neumann Capital Management, LLC first disclosed a stake in GILD in Q3 2023 at 40,190 shares (US$3.0M). The position peaked in Q3 2026 at 37,368 shares, worth US$5.6M. Across 13 filings, Neumann Capital Management, LLC increased the stake 3 time(s), trimmed it 6 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 37,368 shares valued at US$5.6M — an increase of 1,500 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 40.19K $3.01M New
Q4 2023 40.19K $3.26M Hold
Q1 2024 40.99K $3.00M Add
Q2 2024 41.29K $2.83M Add
Q3 2024 39.79K $3.34M Reduce
Q4 2024 39.79K $3.68M Hold
Q1 2025 39.49K $4.42M Reduce
Q2 2025 38.69K $4.29M Reduce
Q3 2025 36.99K $4.11M Reduce
Q4 2025 36.89K $4.53M Hold
Q1 2026 36.07K $5.03M Reduce
Q2 2026 35.87K $4.53M Reduce
Q3 2026 37.37K $5.57M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has Neumann Capital Management, LLC held GILD?

Neumann Capital Management, LLC has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Neumann Capital Management, LLC's current position in GILD?

As of Q3 2026, Neumann Capital Management, LLC holds 37.37K shares of GILD (GILEAD SCIENCES INC), valued at $5.57M, representing 1.42% of its reported portfolio and ranking #18.

Has Neumann Capital Management, LLC been buying or selling GILD?

In the latest 13F filing (Q3 2026), Neumann Capital Management, LLC increased its position in GILD. The position peaked in Q3 2026 at 37.37K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.